glp 1 drugs for perimenopause GLP-1 Medications and Their Role In Menopause Weight Gain GLP-1s, Obesity, and Menopause: Benefits

This review has significant implications for the management of T2D, making it a compelling read for healthcare professionals, researchers, and clinicians

In this respect, the dual agonist effect of tirzepatide seems to give it a superiority on semaglutide, with a greater decrease (more than 2%) in glycated hemoglobin (A1c), a marker of chronic hyperglycemia (Figure 4)

However, real-world studies comparing GLP-1 receptor agonists with DPP-4 inhibitors for the treatment of patients with advanced-stage CKD or ESKD are rare

Pradhan R, Lu S, Yin H, et al

Tirzepatide is also contraindicated in multiple endocrine neoplasia syndrome type-2 (MEN-2)

I enjoy Circle